Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Jeffrey, T. Brummer, M. Rolph, S. Liu, Nuria Callejas, R. Grumont, C. Gilliéron, F. Mackay, S. Grey, M. Camps, C. Rommel, S. Gerondakis, C. Mackay (2006)
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1Nature Immunology, 7
K. Hunter, Nigel Crawford (2006)
Germ line polymorphism in metastatic progression.Cancer research, 66 3
M. Vijver, Yudong He, L. Veer, H. Dai, A. Hart, D. Voskuil, G. Schreiber, J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, Tony Velde, H. Bartelink, S. Rodenhuis, E. Rutgers, S. Friend, René Bernards (2002)
A gene-expression signature as a predictor of survival in breast cancer.The New England journal of medicine, 347 25
Shin-Shu Chang, S. Parker, Tuan Pham, A. Buzdar, S. Hursting (1998)
Inflammatory breast carcinoma incidence and survivalCancer, 82
T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J. Matese, P. Brown, D. Botstein, P. Lønning, A. Børresen-Dale (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 98
Sofia Gruvberger, M. Ringnér, Yidong Chen, Sujatha Panavally, L. Saal, Å. Borg, M. Fernö, Carsten Peterson, P. Meltzer (2001)
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.Cancer research, 61 16
I. Biunno, M. Cattaneo, R. Orlandi, C. Canton, L. Biagiotti, S. Ferrero, Massimo Barberis, S. Pupa, A. Scarpa, S. Ménard (2006)
SEL1L a multifaceted protein playing a role in tumor progressionJournal of Cellular Physiology, 208
S. Schor, J. Haggie, P. Durning, A. Howell, L. Smith, R. Sellwood, D. Crowther (1986)
Occurrence of a fetal fibroblast phenotype in familial breast cancerInternational Journal of Cancer, 37
J. Koblinski, Benjamin Kaplan-Singer, S. VanOsdol, Michael Wu, J. Engbring, Songlin Wang, C. Goldsmith, J. Piper, J. Vostal, J. Harms, D. Welch, H. Kleinman (2005)
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.Cancer research, 65 16
I. Auwera, S. Laere, G. Eynden, I. Benoy, P. Dam, C. Colpaert, S. Fox, H. Turley, A. Harris, E. Marck, P. Vermeulen, L. Dirix (2004)
Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression QuantificationClinical Cancer Research, 10
C. Denoyelle, G. Abou-Rjaily, V. Bezrookove, M. Verhaegen, T. Johnson, D. Fullen, Jenny Pointer, S. Gruber, L. Su, M. Nikiforov, R. Kaufman, B. Bastian, M. Soengas (2006)
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathwayNature Cell Biology, 8
M. Kell, M. Morrow (2005)
Surgical aspects of inflammatory breast cancer.Breast disease, 22
I. Neiman (1974)
[Inflammation and cancer].Patologicheskaia fiziologiia i eksperimental'naia terapiia, 0 4
P. Levine, S. Steinhorn, L. Ries, J. Aron (1985)
Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.Journal of the National Cancer Institute, 74 2
I. Grinberg, KJ Millen (2005)
The ZIC gene family in development and diseaseClinical Genetics, 67
Howard Chang, D. Nuyten, Julie Sneddon, T. Hastie, R. Tibshirani, T. Sørlie, H. Dai, Yudong He, L. Veer, H. Bartelink, M. Rijn, P. Brown, M. Vijver (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.Proceedings of the National Academy of Sciences of the United States of America, 102 10
J. Armes, F. Hammet, M. Silva, J. Ciciulla, S. Ramus, Wee-Kheng Soo, Alexis Mahoney, N. Yarovaya, M. Henderson, K. Gish, A. Hutchins, G. Price, D. Venter (2004)
Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancersOncogene, 23
S. Troup, C. Njue, E. Kliewer, M. Parisien, C. Roskelley, S. Chakravarti, P. Roughley, L. Murphy, P. Watson (2003)
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 1
K. Golen, S. Davies, Z. Wu, Y. Wang, C. Bucana, H. Root, S. Chandrasekharappa, M. Strawderman, S. Ethier, S. Merajver (1999)
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 9
R. Prueitt, B. Boersma, Tiffany Howe, J. Goodman, Douglas Thomas, Lei Ying, Candice Pfiester, H. Yfantis, J. Cottrell, D. Lee, A. Remaley, L. Hofseth, D. Wink, S. Ambs (2007)
Inflammation and IGF‐I activate the Akt pathway in breast cancerInternational Journal of Cancer, 120
N. Mccarthy, Xiaowei Yang, I. Linnoila, M. Merino, S. Hewitt, A. Parr, S. Paik, S. Steinberg, D. Hartmann, N. Mourali, P. Levine, S. Swain (2002)
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 12
C. Perou, T. Sørlie, M. Eisen, M. Rijn, S. Jeffrey, Christian Rees, J. Pollack, D. Ross, H. Johnsen, L. Akslen, Ø. Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley Zhu, P. Lønning, A. Børresen-Dale, P. Brown, D. Botstein (2000)
Molecular portraits of human breast tumoursNature, 406
C. Pyke, S. Salo, E. Ralfkiaer, J. Rømer, K. Danø, K. Tryggvason (1995)
Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.Cancer research, 55 18
Hiroyuki Yamamoto, F. Itoh, S. Iku, M. Hosokawa, K. Imai (2001)
Expression of the g 2 Chain of Laminin-5 at the Invasive Front Is Associated with Recurrence and Poor Prognosis in Human Esophageal Squamous Cell Carcinoma 1
Xiao-Jun Ma, Zuncai Wang, P. Ryan, S. Isakoff, A. Barmettler, Andrew Fuller, B. Muir, G. Mohapatra, R. Salunga, J. Tuggle, Y. Tran, D. Tran, Ana Tassin, Paul Amon, Wilson Wang, Wen Wang, E. Enright, K. Stecker, Eden Estepa-Sabal, Barbara Smith, J. Younger, U. Balis, J. Michaelson, A. Bhan, K. Habin, T. Baer, J. Brugge, D. Haber, M. Erlander, D. Sgroi (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.Cancer cell, 5 6
Y. Sugiyama, Buckminster Farrow, Carlos Murillo, Jing Li, Hiroaki Watanabe, K. Sugiyama, B. Evers (2005)
Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues.Gastroenterology, 128 2
Edward Korn, Lisa Mcshane, J. Troendle, A. Rosenwald, Richard Simon (2002)
Identifying pre-post chemotherapy differences in gene expression in breast tumours: a statistical method appropriate for this aimBritish Journal of Cancer, 86
Xiao-Jun Ma, R. Salunga, J. Tuggle, J. Gaudet, E. Enright, P. Mcquary, T. Payette, M. Pistone, K. Stecker, Brian Zhang, Yixian Zhou, H. Varnholt, Barbara Smith, M. Gadd, Erica Chatfield, J. Kessler, T. Baer, M. Erlander, D. Sgroi, J. Brugge (2003)
Gene expression profiles of human breast cancer progressionProceedings of the National Academy of Sciences of the United States of America, 100
S. Laere, I. Auwera, G. Eynden, S. Fox, F. Bianchi, A. Harris, P. Dam, E. Marck, P. Vermeulen, L. Dirix (2005)
Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray AnalysisBreast Cancer Research and Treatment, 93
A. Orimo, Piyush Gupta, D. Sgroi, F. Arenzana‐Seisdedos, T. Delaunay, R. Naeem, V. Carey, A. Richardson, R. Weinberg (2005)
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 SecretionCell, 121
S. Laere, G. Eynden, I. Auwera, M. Vandenberghe, P. Dam, E. Marck, K. Golen, P. Vermeulen, L. Dirix (2006)
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profilingBreast Cancer Research and Treatment, 95
I. Kurochkin, N. Yonemitsu, S. Funahashi, H. Nomura (2001)
ALEX1, a novel human armadillo repeat protein that is expressed differentially in normal tissues and carcinomas.Biochemical and biophysical research communications, 280 1
K. Hance, W. Anderson, S. Devesa, H. Young, P. Levine (2005)
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.Journal of the National Cancer Institute, 97 13
(2001)
Significance analysis of microarrays applied to the ionizing radiation response
C. Dumur, C. Garrett, K. Archer, S. Nasim, D. Wilkinson, A. Ferreira-Gonzalez (2004)
Evaluation of a linear amplification method for small samples used on high-density oligonucleotide microarray analysis.Analytical biochemistry, 331 2
B. Boersma, Tiffany Howe, J. Goodman, H. Yfantis, D. Lee, S. Chanock, S. Ambs (2006)
Association of breast cancer outcome with status of p53 and MDM2 SNP309.Journal of the National Cancer Institute, 98 13
J. Walshe, S. Swain (2005)
Clinical aspects of inflammatory breast cancer.Breast disease, 22
T. Sørlie, R. Tibshirani, Joel Parker, T. Hastie, J. Marron, A. Nobel, Shibing Deng, H. Johnsen, Robert Pesich, S. Geisler, J. Demeter, C. Perou, P. Lønning, P. Brown, A. Børresen-Dale, D. Botstein (2003)
Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 100
M. Yi, J. Horton, Jonathan Cohen, H. Hobbs, R. Stephens (2006)
WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput dataBMC Bioinformatics, 7
J. Yin, Khalid Mohammad, Khalid Mohammad, Sanna Kakonen, S. Harris, J. Wu-wong, J. Wessale, R. Padley, I. Garrett, J. Chirgwin, J. Chirgwin, T. Guise, T. Guise (2003)
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastasesProceedings of the National Academy of Sciences of the United States of America, 100
C. Sotiriou, S. Neo, L. McShane, E. Korn, Philip Long, A. Jazaeri, P. Martiat, S. Fox, A. Harris, E. Liu (2003)
Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences of the United States of America, 100
B. Vuillermoz, A. Khoruzhenko, Marie-France D'Onofrio, L. Ramont, L. Ventéo, C. Perreau, F. Antonicelli, F. Maquart, Y. Wegrowski (2004)
The small leucine-rich proteoglycan lumican inhibits melanoma progression.Experimental cell research, 296 2
D. Nguyen, Kathy Sam, A. Tsimelzon, Xiaoxian Li, H. Wong, S. Mohsin, G. Clark, S. Hilsenbeck, R. Elledge, D. Allred, P. O’Connell, Jenny Chang (2006)
Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative PhenotypeClinical Cancer Research, 12
C. Kleer, K. Golen, S. Merajver (2000)
Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinantsBreast Cancer Research : BCR, 2
F. Hlubek, A. Jung, N. Kotzor, T. Kirchner, T. Brabletz (2001)
Expression of the Invasion Factor Laminin γ2 in Colorectal Carcinomas Is Regulated by β-CateninCancer Research, 61
Hiroyuki Yamamoto, F. Itoh, S. Iku, M. Hosokawa, K. Imai (2001)
Expression of the γ2 Chain of Laminin-5 at the Invasive Front Is Associated with Recurrence and Poor Prognosis in Human Esophageal Squamous Cell CarcinomaClinical Cancer Research, 7
P. Wülfing, R. Diallo, C. Kersting, C. Wülfing, C. Poremba, A. Rody, R. Greb, W. Böcker, L. Kiesel (2003)
Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 11
H. Dressman, Chris Hans, A. Bild, J. Olson, E. Rosen, P. Marcom, V. Liotcheva, E. Jones, Ž. Vujašković, J. Marks, M. Dewhirst, M. West, J. Nevins, K. Blackwell (2006)
Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant ChemotherapyClinical Cancer Research, 12
R. Tibshirani, T. Hastie, B. Narasimhan, Gilbert Chu (2002)
Diagnosis of multiple cancer types by shrunken centroids of gene expressionProceedings of the National Academy of Sciences of the United States of America, 99
I. Bièche, F. Lerebours, S. Tozlu, M. Espié, M. Marty, R. Lidereau (2004)
Molecular Profiling of Inflammatory Breast CancerClinical Cancer Research, 10
L. Veer, H. Dai, M. Vijver, Yudong He, A. Hart, M. Mao, H. Peterse, K. Kooy, M. Marton, A. Witteveen, G. Schreiber, R. Kerkhoven, C. Roberts, P. Linsley, R. Bernards, S. Friend (2002)
Gene expression profiling predicts clinical outcome of breast cancerNature, 415
M. Katayama, N. Sanzen, A. Funakoshi, K. Sekiguchi (2003)
Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion.Cancer research, 63 1
(1998)
Institute , 1975 – 1992
F. Bertucci, P. Finetti, J. Rougemont, E. Charafe-Jauffret, N. Cervera, C. Tarpin, C. Nguyen, L. Xerri, R. Houlgatte, J. Jacquemier, P. Viens, D. Birnbaum (2005)
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.Cancer research, 65 6
C. Kleer, K. Golen, T. Braun, S. Merajver (2001)
Persistent E-Cadherin Expression in Inflammatory Breast CancerModern Pathology, 14
S. Laere, I. Auwera, G. Eynden, H. Elst, J. Weyler, A. Harris, P. Dam, E. Marck, P. Vermeulen, L. Dirix (2006)
Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.Clinical cancer research : an official journal of the American Association for Cancer Research, 12 11 Pt 1
F. Bertucci, P. Finetti, J. Rougemont, E. Charafe-Jauffret, V. Nasser, B. Loriod, J. Camerlo, R. Tagett, C. Tarpin, G. Houvenaeghel, C. Nguyen, D. Maraninchi, J. Jacquemier, R. Houlgatte, D. Birnbaum, P. Viens (2004)
Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to ChemotherapyCancer Research, 64
B. Ballif, Natalie Mincek, Justin Barratt, M. Wilson, D. Simmons (1996)
Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein.Proceedings of the National Academy of Sciences of the United States of America, 93 11
Alexandra Flemming, T. Brummer, M. Reth, H. Jumaa (2003)
The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansionNature Immunology, 4
D. Pils, P. Horák, A. Gleiss, C. Sax, G. Fabjani, V. Moebus, C. Zielinski, A. Reinthaller, R. Zeillinger, M. Krainer (2005)
Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinomaCancer, 104
The factors that determine whether a breast carcinoma will develop into inflammatory breast cancer (IBC) remain poorly understood. Recent evidence indicates that the tumor stroma influences cancer phenotypes. We tested the hypotheses that the gene expression signature of the tumor stroma is a distinctive feature of IBC. We used laser capture microdissection to obtain enriched populations of tumor epithelial cells and adjacent stromal cells from 15 patients with IBC and 35 patients with invasive, noninflammatory breast cancer (non‐IBC). Their mRNA expression profiles were assessed using Affymetrix GeneChips™. In addition, a previously established classifier for IBC was evaluated for the resulting data sets. The gene expression profile of the tumor stroma distinguished IBC from non‐IBC, and a previously established IBC prediction signature performed better in classifying IBC using the gene expression profile of the tumor stroma than it did using the profile of the tumor epithelium. In a pathway analysis, the genes differentially expressed between IBC and non‐IBC tumors clustered in distinct pathways. We identified multiple pathways related to the endoplasmic stress response that could be functionally significant in IBC. Our findings suggest that the gene expression in the tumor stroma may play a role in determining the IBC phenotype. © 2007 Wiley‐Liss, Inc.
International Journal of Cancer – Wiley
Published: Mar 15, 2009
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.